
U.S. drugmaker AbbVie will invest about 400 million Singapore dollars (some 320 million U.S. dollars) to build a manufacturing plant in Singapore, a local television channel reported Thursday. The plant will be AbbVie's first manufacturing facility in Asia and is expected to be fully operational by 2019, Channel NewsAsia reported. AbbVie is a biopharmaceutical company formed last year following separation from Abbott. It produces drugs including Humira, a rheumatoid arthritis treatment with annual sales of about 12 billion U.S. dollars. The firm is now looking to increase manufacturing capacity to support a product pipeline that it said "is the strongest it has ever been." AbbVie wants to hire more than 250 people for its new plant in Singapore, which will produce drugs for the global market for use in cancer and immunology treatments. The plant will be the first in Singapore that combines both biologics and small molecule, or chemical-based drug manufacturing, in a single facility. The Singapore Economic Development Board said apart from the AbbVie project, the biologics sector has attracted about 2.4 billion Singapore dollars (1.9 billion U.S. dollars) worth of investments in the last seven years. The sector employs about 1, 700 people, and up to 1,000 jobs are expected to be added over the next three to four years.
GMT 12:09 2018 Monday ,26 November
Black Friday less wild as more Americans turn to online dealsGMT 15:06 2018 Sunday ,18 November
Refugee host countries discuss UNRWA's financial crisisGMT 16:17 2018 Monday ,12 November
Egypt working on 4-year plan to increase growth rateGMT 12:45 2018 Friday ,09 November
Egyptian agriculture products introduced to Japanese markeGMT 11:42 2018 Friday ,02 November
Turkey's new mega airport, boon for slowing economyGMT 13:42 2018 Monday ,29 October
Egypt's trade volume hits $67.63 bln over 9 monthsGMT 15:13 2018 Friday ,12 October
Govt to announce incentives package for Overseas PakistanisGMT 14:46 2018 Thursday ,11 October
Economy and energy dominate agenda in Russian-Slovak relationsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor